Mentor Capital, Inc. Speaks on Cancer Investment with Long Island Investment Banking Group

Wed. September 30, 2009; Posted: 11:01 AM

SAN DIEGO, Sep 30, 2009 (BUSINESS WIRE) -- MNTR | Quote | Chart | News | PowerRating -- Mentor Capital, Inc. (Pink Sheets:MNTR) CEO, Chet Billingsley, presented an update of Mentor Capital's rapid progress in advancing its cancer immunotherapy efforts before the Long Island Investment Banking Group. The gathered investment bankers and brokers represented approximately $2 Billion in Assets Under Management and are a major conduit for emerging companies to access the brokerage community.

Mr. Billingsley highlighted the sea change in cancer treatment coming from the immunotherapy sector, which was validated by Dendreon's (DNDN) positive FDA announcement and 1,000% stock rise in March 2009. Both Dendreon, for prostate cancer, and Mentor Capital, for breast cancer, use the same dendritic immunotherapy approach, only with different target cancer surface proteins. In cancer immunotherapy, instead of chemotherapy, surgeries and radiation, the body's own immune system is triggered to attack cancer cells. Patients report only flu-like symptoms as their now activated natural defenses attempt to eradicate or stabilize the targeted cancers.

Both Dendreon and Mentor Capital are prominent in the Cancer Immunotherapy Index. The CI Index is projected to experience an 1100% growth if the total sector projected value keeps pace with the projected sector revenue.

Mentor Capital is a major investor in the Florida based private company, Quantum Immunologics, now in Phase I/II FDA trials for their breast cancer immunotherapy treatment. Additional information on Mentor Capital, and Quantum Immunologics may be referenced at the company website: www.MentorCapital.com.

Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.

SOURCE: Mentor Capital, Inc.

Mentor Capital, Inc. 
Chet Billingsley, CEO 
760-788-4700

For full details for MNTR click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.